Out of the 39 patients who received anemia treatment, approximately 71.8% (28/39) treated with iron therapy, folic acid, vitamin B12, and multivitamins, whereas 28.2% (11/39) underwent blood transfusion and none of the patients treated with erythropoietin-stimulating agents (ESAs) (Table 2). Here, EPO is linked to anemia (phenotype).